Exelixis Inc

www.exelixis.com

210 East Grand Avenue
PO Box 511
South San Francisco
California
CA 94080-0511
United States

+1 650 837 7000

Activities

Manufacturing | Research & Development | Pharmaceutical

Related Companies

Related Content

Ipsen and Exelixis enter into exclusive licensing agreement for cancer therapy cabozantinib
Ipsen and Exelixis enter into exclusive licensing agreement for cancer therapy cabozantinib
NCEs target cancer
NCEs target cancer
Anticancer agent – cabozantinib
Anticancer agent – cabozantinib
Anticancer agent – foretinib
Anticancer agent – foretinib
Anticancer agent – foretinib
Anticancer agent – foretinib